Segui
Jonathan Van Tam
Jonathan Van Tam
Professor of Health Protection, University of Nottingham
Email verificata su nottingham.ac.uk
Titolo
Citata da
Citata da
Anno
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ...
bmj 369, 2020
33082020
The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and …
J Mair-Jenkins, M Saavedra-Campos, JK Baillie, P Cleary, FM Khaw, ...
The Journal of infectious diseases 211 (1), 80-90, 2015
11982015
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score
SR Knight, A Ho, R Pius, I Buchan, G Carson, TM Drake, J Dunning, ...
bmj 370, 2020
9972020
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual …
SG Muthuri, S Venkatesan, PR Myles, J Leonardi-Bee, TSA Al Khuwaitir, ...
The lancet Respiratory medicine 2 (5), 395-404, 2014
7242014
Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study
OV Swann, KA Holden, L Turtle, L Pollock, CJ Fairfield, TM Drake, S Seth, ...
bmj 370, 2020
6952020
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre …
APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ...
The Lancet 398 (10318), 2258-2276, 2021
6562021
Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community
J Yan, M Grantham, J Pantelic, PJ Bueno de Mesquita, B Albert, F Liu, ...
Proceedings of the National Academy of Sciences 115 (5), 1081-1086, 2018
5782018
Middle East respiratory syndrome
YM Arabi, HH Balkhy, FG Hayden, A Bouchama, T Luke, JK Baillie, ...
New England Journal of Medicine 376 (6), 584-594, 2017
5322017
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised …
X Liu, RH Shaw, ASV Stuart, M Greenland, PK Aley, NJ Andrews, ...
The Lancet 398 (10303), 856-869, 2021
4812021
Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study
AC Hayward, EB Fragaszy, A Bermingham, L Wang, A Copas, ...
The Lancet Respiratory Medicine 2 (6), 445-454, 2014
4812014
SARS-CoV-2 (COVID-19): what do we know about children? A systematic review
NS Mehta, OT Mytton, EWS Mullins, TA Fowler, CL Falconer, OB Murphy, ...
Clinical Infectious Diseases 71 (9), 2469-2479, 2020
4522020
Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
AB Docherty, EM Harrison, CA Green, H Hardwick, R Pius, L Norman, ...
MedRxiv, 2020.04. 23.20076042, 2020
4432020
ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ...
Bmj 369, m1985, 2020
3862020
Reduced neutralisation of SARS-CoV-2 omicron B. 1.1. 529 variant by post-immunisation serum
W Dejnirattisai, RH Shaw, P Supasa, C Liu, ASV Stuart, AJ Pollard, X Liu, ...
The Lancet 399 (10321), 234-236, 2022
3592022
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults
B Killingley, AJ Mann, M Kalinova, A Boyers, N Goonawardane, J Zhou, ...
Nature Medicine 28 (5), 1031-1041, 2022
3462022
The epidemiology and clinical impact of pandemic influenza
JS Nguyen-Van-Tam, AW Hampson
Vaccine 21 (16), 1762-1768, 2003
3392003
Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009)
JS Nguyen-Van-Tam, PJM Openshaw, A Hashim, EM Gadd, WS Lim, ...
Thorax 65 (7), 645-651, 2010
3242010
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
RH Shaw, A Stuart, M Greenland, X Liu, JSN Van-Tam, MD Snape
The Lancet 397 (10289), 2043-2046, 2021
3202021
Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study
J Hippisley-Cox, CAC Coupland, N Mehta, RH Keogh, K Diaz-Ordaz, ...
bmj 374, 2021
3102021
Reduction in mortality associated with influenza vaccine during 1989-90 epidemic
AH Ahmed, KG Nicholson, JS Nguyen-Van-Tam
The Lancet 346 (8975), 591-595, 1995
3041995
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20